General Information of Disease (ID: DISJRS1V)

Disease Name Charcot-Marie-Tooth disease type 1B
Synonyms
hereditary motor and sensory neuropathy 1; Charcot-Marie-Tooth disease, slow nerve conduction type, linked to Duffy; CMT 1B; Charcot-Marie-Tooth disease, demyelinating, type 1B; Charcot-Marie-Tooth disease, autosomal dominant, with focally folded myelin sheaths, type 1B; hereditary motor and sensory neuropathy 1B; Charcot-Marie-Tooth neuropathy, type 1B; HMSN1; HMSN 1B; Charcot Marie Tooth disease type 1B; Charcot-Marie-Tooth disease slow nerve conduction type linked to Duffy; Charcot-Marie-Tooth disease type 1 caused by mutation in MPZ; autosomal dominant Charcot-Marie-Tooth disease with focally folded myelin sheaths type 1B; Charcot-Marie-Tooth disease, type 1B; HMSN IB; MPZ Charcot-Marie-Tooth disease type 1; Charcot-Marie-Tooth neuropathy type 1B; HMSN1B; CMT1B; hereditary motor and sensory neuropathy IB
Definition
A sensorineural peripheral polyneuropathy affecting approximately 1 in 2,500 individuals, and is the most common inherited disorder of the peripheral nervous system. Autosomal dominant, autosomal recessive, and X-linked forms have been recognized.
Disease Hierarchy
DIS56F9A: Charcot-Marie-Tooth disease type 1
DISYWZTH: Charcot-Marie-Tooth disease dominant intermediate D
DISJRS1V: Charcot-Marie-Tooth disease type 1B
Disease Identifiers
MONDO ID
MONDO_0007307
MESH ID
D002607
UMLS CUI
C0270912
OMIM ID
118200
MedGen ID
124377
Orphanet ID
101082
SNOMED CT ID
42986003

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
TRPV4 TTKP2SU Strong Biomarker [1]
------------------------------------------------------------------------------------
This Disease Is Related to 9 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
PMP22 OTXWYWCZ Limited Biomarker [2]
SLC25A46 OTFEV9SV Disputed Biomarker [3]
FIG4 OT501PY9 Strong Biomarker [4]
HOXD10 OT0NOWU2 Strong Biomarker [5]
LRSAM1 OTOKWR6C Strong Biomarker [6]
MORC2 OT52A8BJ Strong Biomarker [7]
MPZ OTAR2YXH Definitive Autosomal dominant [8]
MTMR2 OTNCYGBP Definitive Biomarker [9]
SBF2 OTBB8NO8 Definitive Biomarker [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 DOT(s)

References

1 Axonal neuropathy-associated TRPV4 regulates neurotrophic factor-derived axonal growth.J Biol Chem. 2012 Feb 17;287(8):6014-24. doi: 10.1074/jbc.M111.316315. Epub 2011 Dec 20.
2 Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.Lancet Neurol. 2009 Jun;8(6):537-44. doi: 10.1016/S1474-4422(09)70108-5. Epub 2009 May 6.
3 Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder. Nat Genet. 2015 Aug;47(8):926-32. doi: 10.1038/ng.3354. Epub 2015 Jul 13.
4 Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature. 2007 Jul 5;448(7149):68-72. doi: 10.1038/nature05876. Epub 2007 Jun 17.
5 A HOX gene mutation in a family with isolated congenital vertical talus and Charcot-Marie-Tooth disease. Am J Hum Genet. 2004 Jul;75(1):92-6. doi: 10.1086/422015. Epub 2004 May 14.
6 Mutation in the gene encoding ubiquitin ligase LRSAM1 in patients with Charcot-Marie-Tooth disease. PLoS Genet. 2010 Aug 26;6(8):e1001081. doi: 10.1371/journal.pgen.1001081.
7 Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2.Nat Genet. 2017 Jul;49(7):1035-1044. doi: 10.1038/ng.3878. Epub 2017 Jun 5.
8 The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.
9 Sural nerve biopsy and functional studies support the pathogenic role of a novel MPZ mutation.Neuropathology. 2015 Jun;35(3):254-9. doi: 10.1111/neup.12179. Epub 2014 Nov 11.